This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 1997-2004.
Location History:
- Tenafly, NJ (US) (1997)
- Paris, FR (2004)
Company Filing History:
Years Active: 1997-2004
Title: The Innovative Contributions of Marc E Weksler
Introduction
Marc E Weksler is a notable inventor based in Paris, France. He has made significant contributions to the field of neuroscience through his innovative patents. With a total of 2 patents, Weksler's work focuses on diagnosing and treating neurological diseases.
Latest Patents
Weksler's latest patents include groundbreaking inventions that address critical health issues. The first patent, titled "Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder," provides a method for assessing the risk of neurodegenerative diseases, particularly Alzheimer's Disease (AD). This method involves comparing the level of anti-β-amyloid-42 (Aβ) antibody in a biological sample to a normal level, where a lower level indicates a higher risk of the disease.
The second patent, "T cell factors influencing B cell development," relates to an isolated protein or polypeptide produced by T cells that activates B cell production. This invention includes an isolated DNA molecule encoding the protein, which can be used in a recombinant DNA expression system for producing the protein or polypeptide. The isolated protein can be combined with a pharmaceutically acceptable carrier for administration to mammals to stimulate B cell production.
Career Highlights
Marc E Weksler is affiliated with Cornell University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on the diagnosis and treatment of neurological disorders.
Collaborations
Weksler collaborates with fellow researcher Paul Szabo, contributing to the advancement of their shared interests in neuroscience and immunology.
Conclusion
Marc E Weksler's contributions to the field of neuroscience through his patents demonstrate his commitment to addressing significant health challenges. His innovative approaches have the potential to improve the diagnosis and treatment of neurodegenerative diseases.